XNAS
DCGO
Market cap34mUSD
Oct 08, Last price
0.34USD
1D
-1.83%
1Q
-43.27%
IPO
-96.71%
Name
DocGo Inc
Chart & performance
P/E
—
P/S
0.10
EPS
—
Div yield, %
—
Shrs. gr., 5y
-0.23%
Rev. gr., 5y
27.91%
Revenues
322m
-47.74%
Net income
-182m
L
CFO
34m
-51.02%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.
Key people
Independent Chairman of the Board · since 2024
Lee Bienstock
Chief Executive Officer, Director · since 2024
Eiwe Lingefors
Chief Information Officer · since 2024
Stephen Sugrue
Chief Compliance Officer · since 2022
Norman Rosenberg
Chief Financial Officer, Treasurer · since 2023
Ely Tendler
General Counsel, Company Secretary, Director · since 2021
Independent Director · since 2021
Vina Leite
Independent Director · since 2022
Ira Smedra
Independent Director · since 2021
James Travers
Independent Director · since 2021
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||